MyMetabolon Login
© 2020 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Microbiome
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Does Population Health Hold Answers for Precision Medicine?

inPopulation Health

We live in a time of unprecedented good health in the western world – researchers, healthcare professionals, clinicians are all working together to help decrease illness, prevent disease, increase life span and improve quality of life. In the US, for example, the average lifespan for a man in 1950 was 65 years of age.1 By 2007, that number jumped to 75 years of age, and it is expected to continue increasing, which means a growing and aging population for many developed countries around the world.1

by Alex Forrest-Hay, Vice President, Population Health

Population health, or epidemiology, explores the health of large groups of people over time to better understand the underlying nature of wellness and disease. Armed with genetic information and biological samples, as well as a variety of other health information, researchers are creating powerful databases to help explain why some people – and even geographic populations – develop certain diseases and others do not. How much of a role does genetics play compared to a person’s environment? Or, how does living in a congested city with pollution compare to a rural community?

Researchers around the world are gathering genomic and metabolic data from millions of participants to assess the internal and external factors that impact health. This information will help identify important diseases where prevention, diagnosis and treatment are most effective and early detection has the potential to change the outcome.

Metabolon is contributing to these efforts through its Precision Metabolomics™ technology. Unlike genomics, which assesses the risk of developing a disease, metabolomics provides a snapshot of health that gives researchers and clinicians a better understanding of health and the influences of genes, microbiome, diet, lifestyle and drug treatments. Metabolomics also improves understanding of gene function.

Because metabolic data is dynamic and changes with an individual, that information can be used to tailor health care and lifestyle. It is important to remember that clinicians have used metabolites for decades in patient care. To name a few, glucose, creatinine and cholesterol are routinely tested for the diagnosis and management of diabetes, kidney disease and cardiovascular disease. On a certain level, all diseases are metabolic, and there will be a physical manifestation of the disease reflected in our metabolomes. The information gained from metabolomic research provides a foundation to help speed the journey from population health to precision medicine.

I am proud to lead a team that is committed to collecting and providing valuable, integrative knowledge toward understanding gene function and metabolic health. Our Population Health team works with leading government, academic and commercial researchers around the world to establish Metabolon as the preferred provider of metabolomics data for these studies.

Based on our engagement with these groups, there is no doubt that metabolomics is a necessity if these large-scale, multi-omic precision medicine initiatives are going to reshape how medicine is practiced in the 21st century. In addition, the intelligence gained from population health studies could enable Metabolon to develop next-generation clinical tests that will improve patient care and empower an individual to better understand, take control, improve their health and even prevent diseases. We aim to put Precision Metabolomics at the forefront of the precision medicine revolution to improve the outcomes and economics of healthcare.

To learn more about the benefits of adding metabolomics to your large population studies, please contact us.

References

1.      CDC. Table 22. Life expectancy at birth, at 65 years of age, and at 75 years of age, by race and sex: United States, selected years 1900–2007 (2010). Available at https://www.cdc.gov/nchs/data/hus/2010/022.pdf. Accessed 10.3.17.

Back to the Blog
  • Putting the ‘Gee!’ into the Genome: Metabolomics & Human Genomics Studies
    Previous PostPutting the ‘Gee!’ into the Genome: Metabolomics & Human Genomics Studies
  • Next PostPART 1 | Clinical metabolomics is just like basic research metabolomics – right?
    Putting the ‘Gee!’ into the Genome: Metabolomics & Human Genomics Studies

Related Posts

Webinar: Unique advantages of incorporating untargeted and targeted metabolomics in drug development and clinical trials
Events

Webinar: Unique advantages of incorporating untargeted and targeted metabolomics in drug development and clinical trials

Leveraging Machine Learning to Advance Precision Medicine
Press

Leveraging Machine Learning to Advance Precision Medicine

National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study
Company News

National Institute of Allergy and Infectious Disease (NIAID) Selects Metabolon, Inc. for COVID-19 Study

Webinar: Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion
Events

Webinar: Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion

Metabolon’s Client Data Table enables study analysis
Blog Capabilities Working with Metabolon

Metabolon’s Client Data Table enables study analysis

Establishing industry QA/QC best practices for global metabolomics
Capabilities Working with Metabolon

Establishing industry QA/QC best practices for global metabolomics

Webinar: Mechanisms of Immune Control and Metabolomics
Events

Webinar: Mechanisms of Immune Control and Metabolomics

Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies
Company News

Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies

Event: BioProcess International
Events

Event: BioProcess International

Presentation: Leveraging Global Metabolomics at the Intersection of Physiology and Behavior (at MANA 2020)
Events

Presentation: Leveraging Global Metabolomics at the Intersection of Physiology and Behavior (at MANA 2020)

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2021 Metabolon, Inc. All rights reserved. Privacy & Terms

in
Copy
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.